Skip to content

Author

Jing Zhang

We have 2 of 13 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Computed tomography-derived body composition and early changes predict outcomes of first-line chemo-immunotherapy in recurrent/metastatic nasopharyngeal carcinoma

Abstract Background Reliable biomarkers for risk stratification and treatment monitoring in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC) treated with first-line chemo-immunotherapy remain limited. This study evaluated the prognostic value of baseline computed tomography (CT)-derived body composition paramete...

Xia Gan, Zheng-Zheng Yu, Ya-Ning Tang et al. · 0 citations
Open access Sep 2026

GPX3 suppresses lung adenocarcinoma progression through HSPB1 ubiquitination and Hippo pathway activation.

A robust prognostic model based on manganese metabolism-related genes is established and the critical regulatory role of the GPX3/HSPB1/yes-associated protein (YAP) axis in LUAD progression is uncovered, underscoring the therapeutic potential of targeting GPX3.

Si-Xuan Wu, He Huang, Junfan Pan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.